SEQUENOM INC. NEW läuft weiter megamässsig!!

..hiija

lass ich ma gelten

buran

to Sequenom as part of the overall agreement, as well as certain ongoing commitments for payments to Sequenom from the patent pool structure through 2020. www.sequenom.com/press/...esting-intellectual-property-and-end

..haija

so geht das

agreement eliminates confusion over intellectual property rights and provides a single point of contact for those wishing to license this intellectual property for NIPT testing,” said Jay Flatley, Chief Executive Officer for Illumina. www.sequenom.com/press/...esting-intellectual-property-and-end

..yöah

both parties’ NIPT technology by healthcare providers and their patients,” said Bill Welch, Chief Executive Officer of Sequenom.  “We believe that pooling our intellectual property will enable us to continue to expand our NIPT laboratory test offerings while allowing Sequenom to participate more broadly in the growing global NIPT marketplace.”
Separately, Illumina and Sequenom entered into an amended supply agreement whereby Illumina agreed to supply Sequenom with instruments and reagents for an additional five years. www.sequenom.com/press/...esting-intellectual-property-and-end

..yöah

all of their pioneering intellectual property in the NIPT testing field in order to enable and deliver the highest quality NIPT tests to benefit physicians and their patients,” said Tristan Orpin, Senior Vice President and General Manager of Reproductive and Genetic Health for Illumina. www.sequenom.com/press/...esting-intellectual-property-and-end

mariomeierhof@web.de
Tel.:039361/96548 Atelier Meierhof 039361/51273 Kuhle
www.facebook.com/mario.meierhof/photos
39517 Lüderitz Gartenstrasse 6

buran & MARIO

Illumina is transforming human health as the global leader in sequencing and array-based technologies.  The company serves customers in a broad range of markets, enabling the adoption of genomic solutions in research and clinical settings.  To learn how Illumina is unlocking the power of the genome, visit www.illumina.com and follow @illumina. www.sequenom.com/press/...esting-intellectual-property-and-end

Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving health care through revolutionary genomic and genetic analysis solutions. Sequenom develops innovative technologies, products, and diagnostic tests that target and serve molecular diagnostic markets. Web site: www.sequenom.com and follow @SequenomLabs. www.sequenom.com/press/...esting-intellectual-property-and-end

Englischer Begriff für: Aktien-Futures
http://www.ariva.de/extras/lexikon.m?begriff=Equity_Futures